piperaquine has been researched along with Parasitemia in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (22.22) | 29.6817 |
| 2010's | 30 (66.67) | 24.3611 |
| 2020's | 5 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Andrzejewski, C; Batty, KT; Ilett, KF; Jago, JD; Moore, BR; Page-Sharp, M | 1 |
| Anstey, NM; Chalfien, F; Hasugian, AR; Kenangalem, E; Marfurt, J; Penttinen, PM; Piera, KA; Price, RN; Purba, HL; Ratcliff, A; Russell, B; Siswantoro, H; Tjitra, E; Wuwung, RM | 1 |
| Abuaku, B; Amoako, EO; Asamoah, A; Boateng, P; Duah-Quashie, NO; Koram, KA; Malm, KL; Matrevi, SA; Owusu-Antwi, F; Peprah, NY; Quashie, N | 1 |
| Benjamin, JM; Davis, TME; Kasian, B; Kong, C; Laman, M; Moore, BR; Mueller, I; Ome-Kaius, M; Robinson, LJ; Rogerson, S; Tobe, R; Yadi, G | 1 |
| Akakpo, S; Chalon, S; Chughlay, MF; Csermak-Renner, K; Djeriou, E; Gaur, AH; Leboulleux, D; McCarthy, J; Odedra, A; Shanks, GD; Winnips, C | 1 |
| Arsanok, M; Boonyalai, N; Chaisatit, C; Chaorattanakawee, S; Chattrakarn, S; Fagnark, W; Fukuda, MM; Gaywee, J; Gosi, P; Jongsakul, K; Kirativanich, K; Kuntawunginn, W; Lanteri, C; Lertsethtakarn, P; Praditpol, C; Rodkvamtook, W; Sai-Ngam, P; Saunders, DL; Sirisopana, N; Smith, PL; Spring, MD; Sundrakes, S; Ta-Aksorn, W; Thamnurak, C; Utainnam, D; Uthaimongkol, N; Vanachayangkul, P; Vesely, BA; Walsh, D; Waters, NC; Wojnarski, M | 1 |
| Andronescu, LR; Chinkhumba, J; Gutman, JR; Kachepa, W; Kachingwe, M; Laufer, MK; Liang, Y; Mathanga, DP; Peterson, I; Sharma, A | 1 |
| Esu, EB; Meremikwu, MM; Oringanje, C | 1 |
| Abdel Hamid, MM; Adam, MA; Elkando, NS; Elnour, FAA; Malik, EM; Mohamed, AO; Mohamed, OS; Suliman, A | 1 |
| Bouhenia, M; Coldiron, ME; Das, D; Elder, G; Grais, RF; Langendorf, C; Lasry, E; Mwanga, J; Nyehangane, D; Okui, P; Salumu, L | 1 |
| Andrade, BN; Davlantes, E; Dimbu, PR; Dos Santos Souza, S; Félix, J; Ferreira, CM; Florinda Joao, M; Fortes, F; Halsey, ES; Martins, JF; Mbounga, E; Owens, C; Plucinski, MM; Pode, D; Sanhangala, E; Talundzic, E; Udhayakumar, V; Wiesner, L | 1 |
| Bacar, A; Deng, C; Fay, MP; Feng, D; Huang, B; Huang, S; Kéké, RA; Li, D; Li, G; Li, XB; Lin, L; Liu, XH; Lu, F; Mohadji, F; Mohamed, M; Msa Mliva, A; Oithik, F; Said Abdallah, K; Song, J; Su, XZ; Tuo, F; Wang, Q; Wang, X; Wellems, TE; Wu, W; Wu, Z; Xu, Q; Xue, L; Yan, H; Yang, T; Zhang, H; Zheng, S; Zhou, J | 1 |
| Abdulkadir, M; Aderoyeje, T; Agomo, C; Akano, K; Ambe, J; Ebenebe, JC; Emechebe, G; Ezeigwe, NM; Finomo, F; Folarin, OA; Happi, C; Jiya, N; Mokuolu, O; Ntadom, G; Oguche, S; Oyibo, W; Sowunmi, A; Useh, F; Wammanda, R | 1 |
| Bosco, A; Conrad, M; Kalyesubula, S; Kibuuka, A; Kigozi, R; Kyambadde, P; Mulebeke, R; Opigo, J; Rosenthal, PJ; Senzoga, J; Vinden, J; Wallender, E; Yeka, A | 1 |
| Esu, E; Meremikwu, M; Oduwole, O; Okusanya, BO; Olaleye, A | 1 |
| Charlebois, E; Clark, TD; Dorsey, G; Feeney, ME; Havlir, DV; Jagannathan, P; Kakuru, A; Kamya, MR; Muhindo, MK; Nalugo, N; Okiring, J; Olwoch, P; Opira, B; Ruel, T | 1 |
| Beshir, KB; Bousema, T; Chilongola, J; Drakeley, CJ; Hallett, RL; Kaur, H; Mweresa, CK; Ndaro, A; Okell, L; Omar, SA; Sauerwein, RW; Sawa, P; Schallig, HD; Shekalaghe, SA; Sutherland, CJ | 1 |
| Burkholder, B; Bustos, MD; Delacollette, C; Wongsrichanalai, C | 1 |
| Gogtay, N; Kannan, S; Olliaro, PL; Sinclair, D; Thatte, UM | 1 |
| Donegan, S; Gathu, M; Olliaro, PL; Sinclair, D; Zani, B | 1 |
| Anstey, NM; Fobia, W; Kenangalem, E; Lampah, DA; Poespoprodjo, JR; Price, RN; Sugiarto, P; Tjitra, E | 1 |
| Arinaitwe, E; Dorsey, G; Jagannathan, P; Kaharuza, F; Kakuru, A; Kamya, MR; Muhindo, MK; Orukan, F; Osilo, E; Talisuna, A; Tappero, JW | 1 |
| Amuge, P; Brooker, SJ; Dorsey, G; Kamya, MR; Kiwanuka, N; Nankabirwa, JI; Rosenthal, PJ; Staedke, SG; Wandera, B | 1 |
| Achan, J; Arinaitwe, E; Charlebois, E; Clark, TD; Dorsey, G; Havlir, D; Ikilezi, G; Kakuru, A; Kamya, MR; Muhindo, MK; Mwangwa, F; Rosenthal, PJ; Ruel, T; Tappero, JW | 1 |
| Cheah, PY; Day, NP; Dondorp, AM; Fanello, CI; Nosten, F; Onyamboko, MA; Tarning, J; Tshefu, KA; White, NJ; Wongsaen, K | 1 |
| Guo, XR; Huang, F; Li, CF; Li, M; Li, XL; Lin, YX; Liu, H; Nie, RH; Tang, LH; Wang, HY; Wang, J; Wang, JZ; Xu, JW; Yang, HL | 1 |
| Hastings, IM; Hodel, EM; Kay, K | 1 |
| Ategeka, J; Awori, P; Charlebois, ED; Clark, TD; Dorsey, G; Feeney, ME; Havlir, DV; Jagannathan, P; Kakuru, A; Kamya, MR; Muehlenbachs, A; Muhindo, MK; Nakalembe, M; Natureeba, P; Nayebare, P; Olwoch, P; Opira, B; Rizzuto, G | 1 |
| Ashley, EA; Aung, SS; Day, NP; Dhorda, M; Dondorp, AM; Hlaing, TM; Imwong, M; Jeeyapant, A; Promnarate, C; Smithuis, FM; Thein, M; Tun, KM; White, NJ; Woodrow, CJ; Yuentrakul, P | 1 |
| da Luz, RI; Doua, JY; Lutumba, P; Matangila, JR; Mitashi, P; Van Geertruyden, JP | 1 |
| Cao, J; Cao, Y; Culleton, R; Gao, Q; Gu, Y; Li, J; Liu, Y; Lu, F; Menard, D; Pain, A; Ramaprasad, A; Tang, J; von Seidlein, L; Wang, W; Xu, S; Yang, H; Zhang, C; Zhang, M; Zhang, Q; Zhou, H; Zhu, G | 1 |
| Kager, PA; Mens, PF; Omar, SA; Sawa, P; Schallig, HD; van Amsterdam, SM; Versteeg, I | 1 |
| Abiodun, O; Bell, A; Brun, R; Chollet, J; Irungu, BN; Kiboi, DM; Langat, B; Nganga, JK; Nyambati, VC; Nzila, A; Rukunga, GM; Wittlin, S | 1 |
| Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
| Dara, P; Deng, C; Jian, H; Li, G; Ou, F; Seila, S; Socheat, D; Sokunthea, S; Song, J; Tan, B | 1 |
| Arinaitwe, E; Bigira, V; Dorsey, G; Kakuru, A; Kamya, M; Sandison, T; Tappero, JW; Verret, WJ; Wanzira, H | 1 |
| Bentura-Marciano, A; Chan, WC; Clark, J; Golenser, J; Guiguemde, AW; Guo, J; Guy, RK; Haynes, RK; Hunt, NH; Wong, HN | 1 |
| Amansyah, F; Dedang, TA; Driyah, S; Ekowatiningsih, R; Hasugian, AR; Januar, L; Labora, J; Prasetyorini, B; Purnama, A; Purnamasari, T; Salwati, E; Siswantoro, H; Tjitra, E; Wijayanto, B; Yusnita, EA; Yuwarni, E | 1 |
| Dahlan, MS; Hawley, WA; Kosasih, A; Kusriastuti, R; Lobo, NF; Suprijanto, S; Sutanto, I; Syafruddin, D; Ter Kuile, FO | 1 |
| Arinaitwe, E; Bigira, V; Dorsey, G; Homsy, J; Jagannathan, P; Kakuru, A; Kamya, MR; Muhindo, M; Osilo, E; Tappero, JW; Wanzira, H | 1 |
| Binh, TQ; de Vries, PJ; Giao, PT; Hung, le Q; Kager, PA; Nam, NV | 1 |
| Diallo, TO; Doui-Doumgba, K; Flori, P; Garraud, O; Gbagba, FE; Nambei, WS; Ndadjimbaye, V; Ndémanga, J; Perraut, R | 1 |
| Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Stepniewska, K; Thongpraseuth, V; White, NJ | 1 |
| Chollet, J; Santo-Tomas, J; Scheurer, C; Snyder, C; Wittlin, S | 1 |
| Anstey, NM; Fobia, W; Kenangalem, E; Lampah, DA; McGready, R; Poespoprodjo, JR; Price, RN; Seal, A; Sugiarto, P; Tjitra, E; Warikar, N | 1 |
7 review(s) available for piperaquine and Parasitemia
| Article | Year |
|---|---|
Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana.
Topics: Antimalarials; Child; Drug Combinations; Ghana; Humans; Malaria; Malaria, Falciparum; Parasitemia; Treatment Outcome | 2022 |
Intermittent preventive treatment for malaria in infants.
Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemisinins; Bias; Confidence Intervals; Disease Eradication; Drug Combinations; Endemic Diseases; Hospitalization; Humans; Infant; Malaria; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2021 |
A systematic review and meta-analysis of dihydroartemisinin-piperaquine versus sulphadoxine-pyrimethamine for malaria prevention in pregnancy.
Topics: Adult; Antimalarials; Artemisinins; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2019 |
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Quinolines | 2013 |
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria, Vivax; Parasitemia; Primaquine; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Secondary Prevention; Sulfadoxine | 2013 |
Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Quinolines; Randomized Controlled Trials as Topic | 2014 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
20 trial(s) available for piperaquine and Parasitemia
| Article | Year |
|---|---|
A Randomized Open-Label Evaluation of the Antimalarial Prophylactic Efficacy of Azithromycin-Piperaquine versus Sulfadoxine-Pyrimethamine in Pregnant Papua New Guinean Women.
Topics: Adult; Antimalarials; Asymptomatic Diseases; Azithromycin; Chemoprevention; Drug Combinations; Erythrocytes; Female; Gestational Age; Humans; Live Birth; Malaria, Falciparum; Malaria, Vivax; Papua New Guinea; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pyrimethamine; Quinolines; Random Allocation; Severity of Illness Index; Stillbirth; Sulfadoxine | 2019 |
The Effect of Intermittent Preventive Treatment of Malaria During Pregnancy and Placental Malaria on Infant Risk of Malaria.
Topics: Adult; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Infant; Malaria; Malawi; Parasitemia; Piperazines; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Treatment Outcome | 2022 |
Efficacies of DHA-PPQ and AS/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in Sudan.
Topics: Adolescent; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Quinolines; Sudan; Sulfadoxine; Time Factors; Treatment Outcome; Young Adult | 2017 |
Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Comparative Effectiveness Research; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Protozoan Proteins; Quinolines; Recurrence; Single-Blind Method; Uganda | 2019 |
Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial.
Topics: Anemia; Antimalarials; Artemisinins; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Incidence; Infant; Malaria, Falciparum; Male; Parasitemia; Quinolines; Risk Assessment; Uganda; Withholding Treatment | 2019 |
Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence.
Topics: Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chi-Square Distribution; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Infant; Kenya; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Recurrence | 2013 |
Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Kinetics; Longitudinal Studies; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Quinolines; Risk Factors; Uganda | 2014 |
Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial.
Topics: Anemia; Antimalarials; Artemisinins; Child; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Male; Parasitemia; Prevalence; Quinolines; Risk Factors; Uganda | 2014 |
Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children.
Topics: Antimalarials; Artemisinins; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Lopinavir; Malaria; Male; Nevirapine; Parasitemia; Quinolines; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Outcome; Uganda | 2014 |
Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Democratic Republic of the Congo; Drug Combinations; Erythrocyte Count; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Quinolines; Treatment Outcome | 2014 |
Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Incidence; Malaria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Quinolines; Sulfadoxine; Uganda; Vomiting; Young Adult | 2016 |
Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine/pyrimethamine (SP) and SP plus piperaquine in Democratic Republic of the Congo: a randomised controlled trial.
Topics: Adolescent; Anemia; Antimalarials; Chemoprevention; Child; Child, Preschool; Democratic Republic of the Congo; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Hemoglobins; Humans; Malaria; Male; Parasitemia; Pyrimethamine; Quinolines; Schools; Students; Sulfadoxine; Treatment Outcome | 2017 |
A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya.
Topics: Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Blood; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kenya; Malaria, Falciparum; Male; Microscopy; Parasitemia; Plasmodium falciparum; Quinolines; Self-Sustained Sequence Replication; Treatment Outcome | 2008 |
Effect of nutritional status on response to treatment with artemisinin-based combination therapy in young Ugandan children with malaria.
Topics: Antimalarials; Artemisinins; Drug Therapy, Combination; Humans; Infant; Malaria; Malnutrition; Parasitemia; Quinolines | 2011 |
Efficacy and safety of artemisinin-naphthoquine versus dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; DNA, Protozoan; Female; Humans; Indonesia; Malaria; Male; Middle Aged; Naphthoquinones; Parasitemia; Polymerase Chain Reaction; Quinolines; Treatment Outcome; Young Adult | 2012 |
The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Drug Therapy, Combination; Female; Glucosephosphate Dehydrogenase; Humans; Indonesia; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Quinolines; Treatment Outcome; Young Adult | 2013 |
The effects of ACT treatment and TS prophylaxis on Plasmodium falciparum gametocytemia in a cohort of young Ugandan children.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; HIV Infections; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Multivariate Analysis; Parasitemia; Plasmodium falciparum; Post-Exposure Prophylaxis; Prevalence; Proportional Hazards Models; Quinolines; Risk Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Trophozoites; Uganda | 2013 |
CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Atovaquone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Primaquine; Proguanil; Quinolines; Sesquiterpenes; Treatment Outcome; Trimethoprim; Vietnam | 2004 |
Efficacy comparison between anti-malarial drugs in Africans presenting with mild malaria in the Central Republic of Africa: a preliminary study.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Central African Republic; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Parasitic Sensitivity Tests; Patient Compliance; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Trimethoprim | 2005 |
An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Female; Humans; Laos; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Quinolines; Recurrence; Sesquiterpenes; Treatment Failure; Treatment Outcome | 2006 |
18 other study(ies) available for piperaquine and Parasitemia
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Therapy, Combination; Humans; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Quinolines; Sesquiterpenes; Treatment Outcome | 2008 |
In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.
Topics: Adolescent; Age Distribution; Amodiaquine; Animals; Antimalarials; Chloroquine; Confidence Intervals; Drug Resistance; Drug Tolerance; Female; Follow-Up Studies; Humans; Inhibitory Concentration 50; Male; Outpatients; Parasitemia; Plasmodium vivax; Prospective Studies; Recurrence; Rural Health; Time Factors; Treatment Failure; Treatment Outcome | 2009 |
Liver Enzyme Elevations in
Topics: Acrylamides; Adamantane; Adult; Alanine Transaminase; Aminopyridines; Aminoquinolines; Antimalarials; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Erythrocyte Transfusion; Erythrocytes; Female; Ferrous Compounds; Healthy Volunteers; Heterocyclic Compounds, 4 or More Rings; Humans; Indoles; Isoquinolines; Malaria, Falciparum; Male; Metallocenes; Parasitemia; Peroxides; Piperazines; Plasmodium falciparum; Primaquine; Pyrimidines; Quinolines; Spiro Compounds; Sulfones; Triazoles; Young Adult | 2020 |
Plasmodium falciparum phenotypic and genotypic resistance profile during the emergence of Piperaquine resistance in Northeastern Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; DNA Copy Number Variations; DNA, Protozoan; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Female; Genetic Association Studies; Genotype; Haplotypes; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Protozoan Proteins; Quinolines; Thailand; Young Adult | 2021 |
Intermittent preventive treatment for malaria among children in a refugee camp in Northern Uganda: lessons learned.
Topics: Adolescent; Antimalarials; Artemisinins; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Female; Humans; Incidence; Infant; Malaria; Male; Parasitemia; Prevalence; Quinolines; Refugee Camps; Uganda | 2017 |
Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
Topics: Adolescent; Amodiaquine; Angola; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Quinolines; Treatment Failure | 2018 |
Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Comoros; DNA, Protozoan; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Infant; Malaria, Falciparum; Male; Mass Drug Administration; Parasitemia; Plasmodium falciparum; Polymorphism, Genetic; Primaquine; Quinolines; Treatment Outcome; Young Adult | 2018 |
Efficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children Ten Years Following Adoption as First-Line Antimalarials.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Quinolines; Treatment Outcome | 2018 |
Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.
Topics: Acute Disease; Antimalarials; Artemisinins; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Quinolines | 2014 |
In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; China; Drug Resistance; Female; Humans; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Middle Aged; Myanmar; Parasitemia; Plasmodium falciparum; Public Health Surveillance; Quinolines; Young Adult | 2015 |
How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Drug Resistance; Humans; Immunity, Innate; Malaria, Falciparum; Mefloquine; Models, Statistical; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Treatment Outcome | 2015 |
Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin resistance phenotype: a therapeutic efficacy study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Mutation, Missense; Myanmar; Parasitemia; Prospective Studies; Protozoan Proteins; Quinolines; Young Adult | 2016 |
Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa.
Topics: Adult; Africa; Antimalarials; Artemisinins; Asia, Southeastern; Drug Resistance; Drug Therapy, Combination; Equatorial Guinea; Humans; Malaria, Falciparum; Male; Mutation; Papua New Guinea; Parasitemia; Plasmodium falciparum; Polymorphism, Single Nucleotide; Quinolines | 2017 |
Plasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Disease Models, Animal; Drug Resistance; Ethanolamines; Female; Fluorenes; Lumefantrine; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Quinolines; Serial Passage | 2009 |
Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine.
Topics: Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Antimalarials; Artemisinins; Cambodia; Child; Drug Administration Schedule; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Pilot Projects; Plasmodium falciparum; Population Surveillance; Primaquine; Quinolines; Treatment Outcome | 2010 |
Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred C57BL; Microscopy; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Quinolines; Secondary Prevention; Survival Rate | 2012 |
In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Atovaquone; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Erythrocytes; Female; Heterocyclic Compounds, 1-Ring; Humans; Malaria; Mice; Parasitemia; Parasitic Sensitivity Tests; Peroxides; Plasmodium berghei; Plasmodium falciparum; Pyrimethamine; Quinolines; Spiro Compounds | 2007 |
Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.
Topics: Adult; Animals; Antimalarials; Artemisinins; Cross-Sectional Studies; Drug Resistance, Multiple; Endemic Diseases; Female; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Quinolines; Surveys and Questionnaires | 2008 |